Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Long-Term Deferred Tax (2024 - 2025)

Historic Long-Term Deferred Tax for Puma Biotechnology (PBYI) over the last 2 years, with Q3 2025 value amounting to $7.1 million.

  • Puma Biotechnology's Long-Term Deferred Tax changed N/A to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year change of. This contributed to the annual value of $7.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Puma Biotechnology reported Long-Term Deferred Tax of $7.1 million as of Q3 2025.
  • Puma Biotechnology's Long-Term Deferred Tax's 5-year high stood at $7.1 million during Q4 2024, with a 5-year trough of $7.1 million in Q4 2024.